Subtype Prediction of Intrahepatic Cholangiocarcinoma Using Dynamic Contrast-enhanced Ultrasound

Overview

Journal Insights Imaging

Publisher Springer

Specialty Radiology

Date 2024 May 16

PMID 38755299

Authors

Ming-Rui Zhu

Chong-Ke Zhao

Yi-Kang Sun

Xiao-Long Li

Hao-Hao Yin

Dan Lu

Xin Ye

Xin-Yuan Hu

Xi Wang

Han-Sheng Xia

Hong Han

Bo-Yang Zhou

Hui-Xiong Xu

Li-Fan Wang

Affiliations

Soon will be listed here.

Abstract

Objective: The study aimed to investigate the predictive value of dynamic contrast-enhanced ultrasound (DCE-US) in differentiating small-duct (SD) and large-duct (LD) types of intrahepatic cholangiocarcinoma (ICC).

Methods: This study retrospectively enrolled 110 patients with pathologically confirmed ICC lesions who were subject to preoperative contrast-enhanced ultrasound (CEUS) examinations between January 2022 and February 2023. Patients were further classified according to the subtype: SD-type and LD-type, and an optimal predictive model was established and validated using the above pilot cohort. The test cohort, consisting of 48 patients prospectively enrolled from March 2023 to September 2023, was evaluated.

Results: In the pilot cohort, compared with SD-type ICCs, more LD-type ICCs showed elevated carcinoembryonic antigen (p < 0.001), carbohydrate antigen 19-9 (p = 0.004), ill-defined margin (p = 0.018), intrahepatic bile duct dilation (p < 0.001). Among DCE-US quantitative parameters, the wash-out area under the curve (WoAUC), wash-in and wash-out area under the curve (WiWoAUC), and fall time (FT) at the margin of lesions were higher in the SD-type group (all p < 0.05). Meanwhile, the mean transit time (mTT) and wash-out rate (WoR) at the margin of the lesion were higher in the LD-type group (p = 0.041 and 0.007, respectively). Logistic regression analysis showed that intrahepatic bile duct dilation, mTT, and WoR were significant predictive factors for predicting ICC subtypes, and the AUC of the predictive model achieved 0.833 in the test cohort.

Conclusions: Preoperative DCE-US has the potential to become a novel complementary method for predicting the pathological subtype of ICC.

Critical Relevance Statement: DCE-US has the potential to assess the subtypes of ICC lesions quantitatively and preoperatively, which allows for more accurate and objective differential diagnoses, and more appropriate treatments and follow-up or additional examination strategies for the two subtypes.

Key Points: Preoperative determination of intrahepatic cholangiocarcinoma (ICC) subtype aids in surgical decision-making. Quantitative parameters from dynamic contrast-enhanced US (DCE-US) allow for the prediction of the ICC subtype. DCE-US-based imaging has the potential to become a novel complementary method for predicting ICC subtypes.

References

Rhee H, Kim M, Park Y, An C . A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance. Eur Radiol. 2018; 29(6):3111-3121. DOI: 10.1007/s00330-018-5898-9. View

Banales J, Marin J, Lamarca A, Rodrigues P, Khan S, Roberts L . Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020; 17(9):557-588. PMC: 7447603. DOI: 10.1038/s41575-020-0310-z. View

Park S, Lee Y, Kim H, Yu M, Lee E, Yoon J . Subtype Classification of Intrahepatic Cholangiocarcinoma Using Liver MR Imaging Features and Its Prognostic Value. Liver Cancer. 2022; 11(3):233-246. PMC: 9218635. DOI: 10.1159/000521747. View

Huang H, Zhu Z, Zhou Z, Chen L, Zhao M, Zhang Y . Contrast-enhanced transrectal ultrasound for prediction of prostate cancer aggressiveness: The role of normal peripheral zone time-intensity curves. Sci Rep. 2016; 6:38643. PMC: 5144131. DOI: 10.1038/srep38643. View

Hayashi A, Misumi K, Shibahara J, Arita J, Sakamoto Y, Hasegawa K . Distinct Clinicopathologic and Genetic Features of 2 Histologic Subtypes of Intrahepatic Cholangiocarcinoma. Am J Surg Pathol. 2016; 40(8):1021-30. DOI: 10.1097/PAS.0000000000000670. View

Ma B, Meng H, Shen A, Ma Y, Zhao D, Liu G . Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection. Gastroenterol Res Pract. 2021; 2021:6616062. PMC: 8018878. DOI: 10.1155/2021/6616062. View

Zhang X, Zhou Y, Wu Z, Peng W, Li C, Yan L . Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis. Clin Transl Gastroenterol. 2021; 12(11):e00425. PMC: 8580197. DOI: 10.14309/ctg.0000000000000425. View

Nylund K, Saevik F, Leh S, Pfeffer F, Hausken T, Gilja O . Interobserver Analysis of CEUS-Derived Perfusion in Fibrotic and Inflammatory Crohn's Disease. Ultraschall Med. 2018; 40(1):76-84. DOI: 10.1055/s-0044-100492. View

Goossen T, de la Rosette J, Hulsbergen-van de Kaa C, van Leenders G, Wijkstra H . The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol. 2003; 43(2):124-31. DOI: 10.1016/s0302-2838(02)00582-1. View

10.

Dong Y, Qiu Y, Yang D, Yu L, Zuo D, Zhang Q . Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma. Clin Hemorheol Microcirc. 2021; 77(4):461-469. DOI: 10.3233/CH-201085. View

11.

Fujita N, Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y . Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings. Eur Radiol. 2016; 27(2):498-506. DOI: 10.1007/s00330-016-4386-3. View

12.

Wee A . Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis. Cytopathology. 2011; 22(5):287-305. DOI: 10.1111/j.1365-2303.2011.00882.x. View

13.

Wendl C, Janke M, Jung W, Stroszczysnski C, Jung E . Contrast-enhanced ultrasound with perfusion analysis for the identification of malignant and benign tumours of the thyroid gland. Clin Hemorheol Microcirc. 2015; 63(2):113-21. DOI: 10.3233/CH-151966. View

14.

Akita M, Sofue K, Fujikura K, Otani K, Itoh T, Ajiki T . Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma. HPB (Oxford). 2018; 21(2):226-234. DOI: 10.1016/j.hpb.2018.07.021. View

15.

Nagtegaal I, Odze R, Klimstra D, Paradis V, Rugge M, Schirmacher P . The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019; 76(2):182-188. PMC: 7003895. DOI: 10.1111/his.13975. View

16.

Banales J, Cardinale V, Carpino G, Marzioni M, Andersen J, Invernizzi P . Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016; 13(5):261-80. DOI: 10.1038/nrgastro.2016.51. View

17.

Cho M, Moon S, Song T, Kim R, Oh D, Park D . Contrast-Enhanced Endoscopic Ultrasound for Differentially Diagnosing Autoimmune Pancreatitis and Pancreatic Cancer. Gut Liver. 2018; 12(5):591-596. PMC: 6143455. DOI: 10.5009/gnl17391. View

18.

Xiao Y, Zhou C, Ni X, Huang P, Wu F, Yang C . Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma. Cancer Imaging. 2023; 23(1):15. PMC: 9926776. DOI: 10.1186/s40644-023-00533-2. View

19.

Aishima S, Oda Y . Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci. 2014; 22(2):94-100. DOI: 10.1002/jhbp.154. View

20.

Kang H, Kim J, Joo I, Han J . Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2 cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4. Abdom Radiol (NY). 2019; 45(1):55-63. DOI: 10.1007/s00261-019-02132-x. View